LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: In Vivo Stimulation of Therapeutic Antigen-Specific T Cells in an Artificial Lymph Node Matrix.

Livingston, Natalie K / Hickey, John W / Sim, Hajin / Salathe, Sebastian F / Choy, Joseph / Kong, Jiayuan / Silver, Aliyah B / Stelzel, Jessica L / Omotoso, Mary O / Li, Shuyi / Chaisawangwong, Worarat / Roy, Sayantika / Ariail, Emily C / Lanis, Mara R / Pradeep, Pratibha / Bieler, Joan Glick / Witte, Savannah Est / Leonard, Elissa / Doloff, Joshua C /
Spangler, Jamie B / Mao, Hai-Quan / Schneck, Jonathan P

Advanced materials (Deerfield Beach, Fla.)

2024  , Page(s) e2310043

Abstract: T cells are critical mediators of antigen-specific immune responses and are common targets for immunotherapy. Biomaterial scaffolds have previously been used to stimulate antigen-presenting cells to elicit antigen-specific immune responses; however, ... ...

Abstract T cells are critical mediators of antigen-specific immune responses and are common targets for immunotherapy. Biomaterial scaffolds have previously been used to stimulate antigen-presenting cells to elicit antigen-specific immune responses; however, structural and molecular features that directly stimulate and expand naïve, endogenous, tumor-specific T cells in vivo have not been defined. Here, an artificial lymph node (aLN) matrix is created, which consists of an extracellular matrix hydrogel conjugated with peptide-loaded-MHC complex (Signal 1), the co-stimulatory signal anti-CD28 (Signal 2), and a tethered IL-2 (Signal 3), that can bypass challenges faced by other approaches to activate T cells in situ such as vaccines. This dynamic immune-stimulating platform enables direct, in vivo antigen-specific CD8+ T cell stimulation, as well as recruitment and coordination of host immune cells, providing an immuno-stimulatory microenvironment for antigen-specific T cell activation and expansion. Co-injecting the aLN with naïve, wild-type CD8+ T cells results in robust activation and expansion of tumor-targeted T cells that kill target cells and slow tumor growth in several distal tumor models. The aLN platform induces potent in vivo antigen-specific CD8+ T cell stimulation without the need for ex vivo priming or expansion and enables in situ manipulation of antigen-specific responses for immunotherapies.
Language English
Publishing date 2024-02-15
Publishing country Germany
Document type Journal Article
ZDB-ID 1474949-X
ISSN 1521-4095 ; 0935-9648
ISSN (online) 1521-4095
ISSN 0935-9648
DOI 10.1002/adma.202310043
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top